Last reviewed · How we verify
mifepristone-misoprostol treatment
At a glance
| Generic name | mifepristone-misoprostol treatment |
|---|---|
| Also known as | medical abortion |
| Sponsor | Gynuity Health Projects |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion (NA)
- The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy (PHASE4)
- Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage (NA)
- Second Trimester Medical Abortion (NA)
- Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination (NA)
- Medical Termination of II Trimester Pregnancy (PHASE4)
- The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC (NA)
- Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- mifepristone-misoprostol treatment CI brief — competitive landscape report
- mifepristone-misoprostol treatment updates RSS · CI watch RSS
- Gynuity Health Projects portfolio CI